<p>Radiation-induced lung injury (RILI) represents a critical complication associated with radiation exposure, requiring targeted treatment strategies in clinical practice. Here, we pioneered the extraction of extracellular vesicles (EVs) from <i>Chlorella</i> and innovatively developed a multifunctional nanogel platform (RU.521-EVs NPs) by combining them with the cGAS inhibitor RU.521. The&#xa0;<i>Chlorella</i>-derived EVs possess a naturally high abundance of antioxidant enzymes (e.g., SOD2, CAT) and anti-inflammatory lipids (e.g., linolenic acid). RU.521-EVs NPs could synergistically inhibit excessive activation of the cGAS-STING pathway, and significantly reduce the secretion of pro-inflammatory factors. In the RILI mouse model, the nanogel demonstrated significant anti-inflammatory and anti-fibrosis activity, with no observed systemic toxicity. Their biological safety, cost-effectiveness, and multifaceted anti-radiation mechanisms of nanogels make them particularly beneficial in contexts such as medical radiation exposure, providing a strategy for the clinical translation of RILI that emphasizes both safety and long-term efficacy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Chlorella-derived extracellular vesicle-based nanogels suppress cGAS-STING for treatment of radiation-induced lung injury

  • Huiqun Hu,
  • Feng Lu,
  • Wenting Zhang,
  • Zengwen Zhang,
  • Jiarong Cui,
  • Xiaoyue Lei,
  • Jingyan Xia,
  • Feng Xu

摘要

Radiation-induced lung injury (RILI) represents a critical complication associated with radiation exposure, requiring targeted treatment strategies in clinical practice. Here, we pioneered the extraction of extracellular vesicles (EVs) from Chlorella and innovatively developed a multifunctional nanogel platform (RU.521-EVs NPs) by combining them with the cGAS inhibitor RU.521. The Chlorella-derived EVs possess a naturally high abundance of antioxidant enzymes (e.g., SOD2, CAT) and anti-inflammatory lipids (e.g., linolenic acid). RU.521-EVs NPs could synergistically inhibit excessive activation of the cGAS-STING pathway, and significantly reduce the secretion of pro-inflammatory factors. In the RILI mouse model, the nanogel demonstrated significant anti-inflammatory and anti-fibrosis activity, with no observed systemic toxicity. Their biological safety, cost-effectiveness, and multifaceted anti-radiation mechanisms of nanogels make them particularly beneficial in contexts such as medical radiation exposure, providing a strategy for the clinical translation of RILI that emphasizes both safety and long-term efficacy.